Pratt, J. Peter, Chandler-Oatts, Jacqueline, Nelstrop, Louise, Branford, David, Pereira, Stephen M. and Johnston, Susan. (2008) Establishing gold standard approaches to rapid tranquillisation: a review and discussion of the evidence on the safety and efficacy of medications currently used. Journal of Psychiatric Intensive Care, Vol.4 (No.1-2). pp. 43-57. ISSN 1742-6464

Preview

PDF WRAP_Pratt_establishing_gold.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (175Kb)

Abstract

Background: Rapid tranquillisation is used when control of agitation, aggression or excitement is required. Throughout the UK there is no consensus over the choice of drugs to be used as first line treatment. The NICE guideline on the management of violent behaviour involving psychiatric inpatients conducted a systematic examination of the literature relating to the effectiveness and safety of rapid tranquillisation (NICE, 2005). This paper presents the key findings from that review and key guideline recommendations generated, and discusses the implications for practice of more recent research and information. Aims: To examine the evidence on the efficacy and safety of medications used for rapid tranquillisation in inpatient psychiatric settings. Method: Systematic review of current guidelines and phase III randomised, controlled trials of medication used for rapid tranquillisation. Formal consensus methods were used to generate clinically relevant recommendations to support safe and effective prescribing of rapid tranquillisation in the development of a NICE guideline. Findings: There is a lack of high quality clinical trial evidence in the UK and therefore a ‘gold standard’ medication regime for rapid tranquillisation has not been established. Rapid tranquillisation and clinical practice: The NICE guideline produced 35 recommendations on rapid tranquillisation practice for the UK, with the primary aim of calming the service user to enable the use of psychosocial techniques. Conclusions and implications for clinical practice: Further UK specific research is urgently needed that provides the clinician with a hierarchy of options for the clinical practice of rapid tranquillisation.

Item Type:	Journal Article
Subjects:	R Medicine > R Medicine (General) B Philosophy. Psychology. Religion > BF Psychology
Divisions:	Faculty of Social Sciences > School of Health and Social Studies
Library of Congress Subject Headings (LCSH):	Benzodiazepines, Antipsychotic drugs, Aggressiveness, Violence in psychiatric hospitals, Medicine and psychology, Mental illness -- Treatment, Psychiatry
Journal or Publication Title:	Journal of Psychiatric Intensive Care
Publisher:	Cambridge University Press
ISSN:	1742-6464
Date:	December 2008
Volume:	Vol.4
Number:	No.1-2
Page Range:	pp. 43-57
Identification Number:	10.1017/S1742646408001234
Status:	Not Peer Reviewed
Access rights to Published version:	Open Access
Funder:	National Institute for Health and Clinical Excellence (Great Britain) (NICE)
References:	Aleman, A. and Kahn, R.S. (2001) Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: A meta-analysis of controlled trials. European Neuropsychopharmacology. 11: 289–293. Alexander, J., Tharyan, P., Adams, C., John, T., Mol, C. and Philip, J. (2004) Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine. British Journal of Psychiatry. 185: 63–69. Battaglia, J., Moss, S., Rush, J., Kang, J., Mendoza, R., Leedom, L., Dubin, W., McGlynn, C. and Goodman, L. (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective double-blind, emergency department study. American Journal of Emergency Medicine. 15(4): 335–340. Beer, M.D., Paton, C. and Pereira, S.M. (2001) Management of acutely disturbed behaviour. In: Beer, M.D, Pereira, S.M., Paton, C. (eds). Psychiatric Intensive Care. London: Greenwich Medical Media. p.25. Bieniek, S.A., Ownby, R.L., Penalver, A., and Domingues, R.A. (1998) A double-blinded study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy. 18: 57–62. Binder, R.L. and McNiel, D.E. (1999) Contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms. Psychiatric Services. 50(12): 1553–1554. Brier, A., Meehan, K., Birkett, M., David, S., Ferchland, I., Sutton, V., Taylor, C.C., Palmer, R., Dossenbach, M., Kiesler, G., Brook, S. and Wright, P. (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Archive of General Psychiatry. 59: 441–448. Broadstock, M. (2001) The Effectiveness and Safety of Drug Treatment for Urgent Sedation in Psychiatric Emergencies: A Critical Appraisal of the Literature. New Zealand Health Technology Assessment Report 2001; 4(1). Brook, S., Lucey, J.V. and Gunn, K.P. (2000) Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Journal of Clinical Psychiatry. 61(12):933–941. Burgess, S. (1997) Emergency drug treatment of disturbed psychotic patients. Auditorium. 6(1):28–30. Corrigan, J.D. (1989) Development of a scale of assessment of agitation following traumatic brain injury. Journal of Clinical and Experimental Neuropsychology. 11(2): 261–277. Cunnane, J.G. (1994) Drug management of disturbed behaviour by psychiatrists. Psychiatric Bulletin. 18: 138–139. Day, C.P., James, O.F.W., Butler, T.J., and Campbell, R.W.F. (1993) QT prolongation and sudden death in patients with alcoholic liver disease. Lancet. 341:1423–1428. Dorevitch, A., Katz, N., Zemishlany, Z., Aizenberg, D. and Weizman, A. (1999) Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. American Journal of Psychiatry. 156(1): 142–144. Drake, W.M., and Broadhurst, P.A. (1996) QT-interval prolongation with ecstasy. South African Medical Journal. 86: 180–181. Drici, M.D., Wang, W.X., Li, X., Woosley, R.L. and Flockhart, D.A. (1998) Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. Journal of Clinical Psychopharmacology. 18: 477–481. Eccles, M. and Mason, J. (2001) How to Develop Cost Conscious Guidelines. Health Technology Assessment; 5(16). London: NICE. Foster, S., Kessel, J., Berman, M.E. and Simpson, G.M. (1997) Efficacy of lorazepam and haloperidol for rapid tranquillisation in a psychiatric emergency room setting. International Clinical Psychopharmacology. 12(3):175–179. Fruensgaard, K., Karsgaard, S., Jøgenson, H. and Jenson, K. (1977) Loxapine versus haloperidol parenterally in acute psychosis with agitation. Acta Psychiatrica Scandanavia. 56: 256–264. Garza-Trevino, E.S., Hollister, L.E., Overall, J.E. and Alexander, W.F. (1989) Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. American Journal of Psychiatry. 146(12): 1598–1601. Gibson, R.C., Fenton, M., da Silva Freire Coutinho, E. and Campbell, C. (2000) Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD000525. DOI: 10.1002/14651858.CD000525.pub2 Guy, W. (1976) ECDEU Assessment Manual for Psychopathology. Rockville, MD: Department of Health Education and Welfare, National Institute of Mental Health. pp. 217–222. Holmes, C., Simmons, H. and Pilowsky, L. (2001) Rapid tranquillisation. In: Beer, M.D, Pereira, S.M., Paton, C. (eds). Psychiatric Intensive Care. London: Greenwich Medical Media. p.47. Huf, G., Alexander, J. and Allen, M.H. (2004) Haloperidol and promethazine for psychosis induced aggression. Cochrane Database of Systematic Reviews. 2004, Issue 4. Art no: CD005146.DOI: 10.1002/14651858.CD005146. Huf, G., Coutinho, E.S.F., Adams, C.E. and TREC Collaborative Group (2007) Rapid tranquillisation in psychiatric emergency settings in Brazil: Pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol and promethazine. British Medical Journal. 335: 869. Kay, S.R., Fiszbein, A. and Opler, L.A. (1992) Positive and Negative Syndrome Scale (PANSS) Manual. Toronto: Multi-Health Systems. Makkar, R.R., Fromm, B.S., Steinman, R.T., Meissner, M.D. and Lehmann, M.H. (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Journal of the American Medical Association. 270(21):2590–2597. Mason, J., Nicolson, D., and Wilson, D. (2002) Systematic review methods for national guidelines. Unpublished discussion paper. McAllistair-Williams, R.H. and Ferrier, I.N. (2002) Rapid tranquillisation: Time for a reappraisal of options for parenteral therapy. British Journal of Psychiatry. 180: 485–489. National Collaborating Centre for Mental Health (2002) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: NICE. www.nice.org.uk/nicemedia/pdf/CG1NICEguideline.pdf NICE (2005) Clinical Guideline 25. Violence: The Short-Term Management of Disturbed/Violent Behaviour in Psychiatric In-Patient Settings and Emergency Departments. London: NICE. www.nice.org.uk/guidance/index.jsp?action=byID&o=10964 NICE Technical Manual (2004) Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: NICE. Overall, J. and Gorham, P. (1962) The Brief Psychiatric Rating Scale. Psychology Reports. 22: 788–812. Paprocki, J. and Versiani, M. (1977) A double blinded comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. Current Therapeutic Research. 21(1):80–100. OpenURL PubMed Google Scholar Pereira, R., Kraebber, A., and Schwartz, M. (1997) Prolonged QT interval and cocaine use. Journal of Electrocardiology. 30: 337–339. Rautaharju, P., Zhou, S.H., Wong, S., Calhoun, H.P., Berenson, G.S., Prineas, R. and Davignon, A. (1992) Sex differences in the evolution of the electrocardiographic QT interval with age. Canadian Journal of Cardiology. 8: 690–695. Raveendran, N.S., Tharyan, P., Alexander, J. and Elliot, C. (2007) Rapid tranquillisation in psychiatric emergency settings in India: Pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. British Medical Journal. 335: 865. Ray, W.A., Meredith, S., Thapa, P.B., Meador, K.G., Hall, K. and Murray, K.T. (2001) Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry. 58: 1161–1167. Reilly, J.R. (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. The Lancet. 355(35): 1048–1052. Reschke, R.W. (1974) Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Diseases of the Nervous System. 35(3):112–115. Royal College of Nursing (2005) Violence: The Short Term Management of Disturbed/Violent Behaviour in In-Patient Psychiatric Settings and Emergency Departments. London: RCN. www.rcn.org.uk/development/practice/clinicalguidelines/violence Royal College of Psychiatrists (1997) The Association Between Antipsychotic Drugs and Sudden Death: Report of the Working Group of the Royal College of Psychiatrists' Psychopharmacology Sub-Group. Council Report CR57. London: Royal College of Psychiatrists. Royal College of Psychiatrists (1998) Management of Imminent Violence: Clinical Practice Guidelines to Support Mental Health Services. OP41. London: Royal College of Psychiatrists. TREC Collaborative Group (2003) Rapid tranquillisation for agitated patients in emergency psychiatric rooms: A randomised trial of midazolam versus haloperidol plus promethazine. British Medical Journal. 327: 708–713. Tuason, V.B. (1986) A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients. Journal of Clinical Psychiatry. 47: 126–129. Warner, J.P., Barnes, T.R.E. and Henry, J.A. (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatrica Scandinavica. 93: 311–313. Wright, P., Birkett, M., David, S.R., Meehan, K., Ferchland, I., Alaka, K.J., Saunders, J.C., Kreuger, J., Bradley, P., San, L., Bernardo, M., Reinstein, M. and Brier, A. (2001) Double-blind, placebo-controlled comparison of intramusclar olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. American Journal of Psychiatry. 158(7):1149–1151. Wright, S., Gray, R., Parkes, J. and Gournay, K. (2002) The Recognition, Prevention and Therapeutic Management of Violence in Acute In-Patient Psychiatry: A Literature Review and Evidence-Based Recommendations for Good Practice. London: United Kingdom Central Council for Nursing, Midwifery and Health Visiting. Wyant, M., Diamond, B.I., O'Neal, E., Sloan, A. and Borison, R.L. (1990) The use of midazolam in acutely agitated psychiatric patients. Psychopharmacology Bulletin. 26(1): 126–129. Yudofsky, S.C., Kopecky, H.J., Kunik, M., Silver, J.M., and Endicott, J. (1997) The overt agitation severity scale for the objective rating of agitation. Journal of Neuropsychiatry and Clinical Neuroscience. 9(4):541–548.
URI:	http://wrap.warwick.ac.uk/id/eprint/869

Request changes to a record

Actions (login required)

View Item